Results 151 to 160 of about 60,975 (303)
A quantitative dissection of the DNA‐binding properties of pathogenic GATA1 mutants
Transcription factor activity is influenced by cell context, accessibility of target sequences, and co‐factor recruitment. Quantitatively characterizing the consequences of individual mutations in the transcription factors or their target sequences remains technically challenging. Zambo et al. use mutant GATA1‐ATP2B4 binding to illustrate an innovation
Kaoru Takasaki
wiley +1 more source
RASGRP1 Deficiency Manifesting as Severe Vasculopathy and Fatal Autoimmune Hemolytic Anemia. [PDF]
Ashari KA +5 more
europepmc +1 more source
Hair‐on‐end sign in severe sickle cell disease
British Journal of Haematology, EarlyView.
Raquel da Costa Neves +2 more
wiley +1 more source
ABSTRACT Introduction Neutrophil‐extracellular traps are net‐like material released by triggered neutrophils and composed of decondensed chromatin linked to nuclear proteins. Elastase, one of the fourth most represented neutrophil‐specific serine proteases stored in azurophil granules of naïve neutrophils, exerts various actions, including degradation ...
Pasqualina Scala +14 more
wiley +1 more source
Hemolytic Anemia in Liver Disease: A Case of Spur Cell Anemia. [PDF]
El Amri H, Reddy AP, Azhar W, Junaid B.
europepmc +1 more source
ABSTRACT Introduction The Atellica HEMA 580 is a novel haematology analyser providing eight‐part leukocyte differential and optical platelet (PLT) counting. We compared its analytical and clinical performance with that of the ADVIA 2120i. Methods A total of 796 residual whole blood specimens were analysed.
Hyeongyu Lee +3 more
wiley +1 more source
Novel ABCG8 Mutation in Pediatric Sitosterolemia: A Case Report of Siblings with Hemolytic Anemia. [PDF]
Saha S, Dolai TK, Ghosh K, Jajodia E.
europepmc +1 more source
Management of autoimmune hemolytic anemia. [PDF]
Barcellini W, Fattizzo B.
europepmc +1 more source
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare condition. The pathogenesis is incompletely understood; however, interleukin‐6 (IL‐6) is a major mediator. The clinical presentation is heterogeneous, from mild constitutional symptoms to severe multi‐organ failure.
Dipti Talaulikar +16 more
wiley +1 more source

